Sign in Subscribe
Vaccination

South Africa Adapts Vaccination Plan Amid Emerging COVID-19 Variant

Strategic Insights

— 1 min read

South Africa has modified its phase one vaccination plan, shifting from the AstraZeneca vaccine to the Johnson and Johnson vaccine, citing its proven efficacy against the 501Y.V2 COVID-19 variant. The Johnson and Johnson vaccine has shown promising results, with Health Minister Dr. Zweli Mkhize stating that it has been proven effective against the emerging variant. Meanwhile, the country has secured shots from Pfizer, which are expected to arrive sooner than initially planned.

Key Takeaways:

  • The South African government has switched from the AstraZeneca vaccine to the Johnson and Johnson vaccine for phase one of its vaccination plan, citing the latter's effectiveness against the 501Y.V2 COVID-19 variant.
  • The Johnson and Johnson vaccine has been proven effective against the 501Y.V2 variant, allowing the government to proceed with its vaccination plan.
  • The country has secured shots from Pfizer, which are expected to arrive sooner than initially planned.
  • Local scientists are working with other vaccine manufacturers, including Sinopharm, Moderna, and the University of Oxford's AstraZeneca, to procure additional vaccine supplies.
  • The government intends to sell the AstraZeneca vaccine to other countries since it has already been widely used globally and there is a high demand for it.
  • The South African government has emphasized the importance of preventing the spread of COVID-19 through hand washing, mask wearing, and social distancing until the country reaches herd immunity.

Statistics:

  • The Johnson and Johnson vaccine has been proven effective against the 501Y.V2 COVID-19 variant.
  • The Pfizer vaccine is expected to arrive in South Africa sooner than initially planned.
  • The AstraZeneca vaccine has been widely used globally, with many countries expressing interest in purchasing it.
  • The South African government has secured shots from Johnson and Johnson and Pfizer for its vaccination campaign.
  • The government is considering selling the AstraZeneca vaccine to other countries.

Sources:

  • South African Government News Agency (2021, February 10)

Read more